Home / Inspections / 1264395

FDA Inspection 1264395 — Medpace Core Laboratories, LLC

Medpace Core Laboratories, LLC — FEI 3005524314

The FDA completed an inspection of Medpace Core Laboratories, LLC on March 4, 2025 in Cincinnati, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 4, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Cincinnati, OH (United States)

Facility

Other inspections at this facility

  • 1252811 (NAI Mon Oct 21 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1201277 (NAI Thu Mar 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources